China Approves First Commercial Invasive Brain-Computer Interface Device

China's National Medical Products Administration (NMPA) has granted marketing approval for the world's first invasive brain-computer interface (BCI) medical device, aimed at assisting patients with paralysis in regaining hand function. Developed by Neuracle Medical Technology in Shanghai, this device is designed specifically for adults aged 18 to 60 who suffer from quadriplegia due to cervical spinal cord injuries. The approval allows the device to be sold for clinical use, marking a significant milestone in the field of neurotechnology.

China Approves World’s First Invasive BCI DeviceInteresting EngineeringChina approves world's first invasive brain-computer interface medical deviceChina Approves First Commercial Use of Neuroimplant

The invasive BCI device operates by implanting electrodes that capture neural signals from the brain. Unlike traditional methods that penetrate deep brain tissue, this device employs a minimally invasive extradural implantation technique, placing electrodes outside the dura layer of the brain. This design minimizes surgical trauma while ensuring long-term stability. The system translates brain signals into commands that activate a robotic glove, enabling patients to perform basic hand movements, such as grasping objects. Clinical trials have shown significant improvements in hand function among participants, enhancing their quality of life.

Interesting EngineeringChina approves world's first invasive brain-computer interface medical deviceChina Approves World’s First Invasive BCI DeviceChina Approves First Commercial Use of Neuroimplant

The approval of this BCI device comes at a time when China is prioritizing neurotechnology as a key area for development. The country has approximately 3.74 million spinal injury patients, with 90,000 new cases reported annually. Experts believe that the successful commercialization of this device could accelerate the development of similar technologies, positioning China as a leader in the neurotechnology sector. The Chinese government is actively supporting startups in this field, aiming to establish a robust industry over the coming years.

China Approves First Commercial Use of Neuroimplant

While the approval is seen as a breakthrough, there are limitations to the device's application. It is only suitable for patients who retain some upper arm movement, which restricts its use to a specific subset of individuals with paralysis. Critics have pointed out that the device's capabilities may not match those of more advanced competitors, such as Neuralink, which is also developing implantable devices for restoring movement in patients with severe neurological conditions.

Interesting Engineering

Peng Liang, deputy director of the First Evaluation Department in the Center for Medical Device Evaluation of the NMPA, stated, "This device fills a clinical gap both domestically and internationally, making a zero-to-one breakthrough for invasive BCI medical devices worldwide." He emphasized the importance of real-time analysis and interaction with external devices for BCI medical devices, distinguishing them from consumer-grade products.

China approves world's first invasive brain-computer interface medical device

The approval of this invasive BCI device is expected to pave the way for further advancements in rehabilitation technologies for patients with neurological impairments. As the technology matures, experts anticipate that similar devices will enter practical public use within the next three to five years, potentially transforming the landscape of assistive medical technologies.

China Approves World’s First Invasive BCI Device